The global market for weight management drugs is seeing dynamic growth and increasing demand for powerful self-injection systems. Schreiner MediPharm, a leading developer and manufacturer of innovative functional labels for the healthcare industry, has developed a multifunctional specialty label for SHL Medical’s Quanta Pen. The label combines user convenience, safety, and digital connectivity.
Consistent performance
The newly developed functional label from Schreiner MediPharm is an ideal complement to the Quanta Pen from SHL Medical, an injector platform specifically designed for long-term cardiometabolic therapies. The multi-fixed-dose pen platform combines fixed-dose reliability with a no-priming design to deliver consistent performance across repeated injections while supporting cost-efficient treatment delivery. Schreiner MediPharm’s precision-fit label adds functional and digital features to the pen.
As demand for weight management therapies continues to grow, pharmaceutical companies are increasingly focused on solutions that support scalability, usability, and differentiation. The combination of SHL Medical’s Quanta Pen and Schreiner MediPharm’s functional label brings these elements together by combining a multi-fixed-dose pen platform with value-adding label technologies. The label from Schreiner MediPharm carries SHL Medical’s branding and integrates functional value-adding features such as an anti-slip varnish for better grip and safe handling, as well as a holographic effect as an overt authentication feature to enhance the design. Together, the pen and label can support implementation efficiency while strengthening the overall product presentation.
NFC functionality
As a special feature, the label includes an NFC chip, enabling a variety of possibilities for digital applications. Product information, user instructions, or service offerings can simply be accessed by the end user by means of a smartphone. At the same time, the functional label offers further options for customised differentiation. Additional security, design, and functional elements can be flexibly integrated and enable targeted adaptation to the product brand and application.
The joint project by Schreiner MediPharm and SHL Medical combines the strengths of two leading specialists. While SHL Medical provides a powerful platform for modern self-injection solutions with the Quanta Pen, Schreiner MediPharm complements it with smart label technologies. The result is a flexible total solution enhancing functionality, connectivity, and brand appearance while opening up new differentiation potential for pharmaceutical companies.